OncoCyte Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:OCX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
05 Dec 24	BuyUS$45,800	Andrea James	Individual	20,000	US$2.29
02 Oct 24	BuyUS$3,877,619	Broadwood Capital, Inc.	Company	1,315,339	US$2.95
02 Oct 24	BuyUS$100,000	Andrea James	Individual	33,670	US$2.97
11 Apr 24	BuyUS$99,999	Andrew Arno	Individual	33,898	US$2.95
11 Apr 24	BuyUS$10,001	Joshua Riggs	Individual	3,390	US$2.95
11 Apr 24	BuyUS$7,057,688	Broadwood Capital, Inc.	Company	2,420,000	US$2.92

Insider Trading Volume

Insider Buying: OCX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OCX?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	0	0%
Institutions	1,221,487	7.26%
Public Companies	1,510,944	8.97%
Individual Insiders	1,711,589	10.2%
General Public	5,049,647	30%
Hedge Funds	7,341,580	43.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 103.8%.

Top Shareholders

Top 25 shareholders own 70% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
37.1%	Broadwood Capital, Inc.	6,244,405	US$13.7m	26.7%	1.05%
9.26%	Patrick Smith	1,558,437	US$3.4m	0%	no data
8.97%	Bio-Rad Laboratories, Inc.	1,510,944	US$3.3m	25.9%	no data
6.52%	AWM Investment Company Inc	1,097,175	US$2.4m	0%	0.29%
2.94%	Pura Vida Investments, LLC	495,345	US$1.1m	0%	2.09%
1.46%	The Vanguard Group, Inc.	245,388	US$537.4k	0.37%	no data
0.62%	Geode Capital Management, LLC	103,980	US$227.7k	12.2%	no data
0.5%	Andrew Arno	84,662	US$185.4k	0%	no data
0.47%	BlackRock, Inc.	79,833	US$174.8k	9.62%	no data
0.43%	Morgan Stanley, Investment Banking and Brokerage Investments	72,289	US$158.3k	-8.14%	no data
0.41%	Lockheed Martin Corporation Master Retirement Trust	69,072	US$151.3k	0%	100.0%
0.35%	Defender Capital LLC	59,353	US$130.0k	7.48%	0.04%
0.32%	Andrea James	53,670	US$117.5k	0%	no data
0.25%	FNY Investment Advisers, LLC	42,896	US$93.9k	81.4%	0.05%
0.12%	State Street Global Advisors, Inc.	19,554	US$42.8k	0%	no data
0.1%	Northern Trust Global Investments	17,346	US$38.0k	0%	no data
0.059%	Abaris Investment Management AG	10,000	US$21.9k	0%	0.03%
0.03%	Ekkehard Schutz	5,085	US$11.1k	1,520%	no data
0.027%	Andrew Last	4,509	US$9.9k	79.7%	no data
0.021%	Joshua Riggs	3,505	US$7.7k	0%	no data
0.01%	Lord, Abbett & Co. LLC	1,675	US$3.7k	0%	no data
0.0093%	Louis Silverman	1,564	US$3.4k	0%	no data
0.0086%	Tower Research Capital Europe Limited	1,446	US$3.2k	-52.9%	no data
0.0064%	Advisor Group Holdings, Inc., Asset Management Arm	1,080	US$2.4k	0%	no data
0.005%	UBS Asset Management AG	835	US$1.8k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 08:14
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OncoCyte Corporation is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Mark Massaro	BTIG
Keay Nakae	Chardan Capital Markets, LLC
Paul Knight	Janney Montgomery Scott LLC